Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
FOXO Technologies ( (FOXO) ) has shared an update.
On September 9, 2025, FOXO Technologies Inc. entered into a Stock Purchase Agreement with Vector BioSource Inc. to acquire all of its equity securities. The acquisition involves a combination of cash, preferred stock, and warrants, with additional shares contingent on Vector’s revenue performance. This strategic move aims to enhance FOXO’s market position and operational capabilities, with the closing subject to due diligence and other conditions.
Spark’s Take on FOXO Stock
According to Spark, TipRanks’ AI Analyst, FOXO is a Underperform.
FOXO Technologies receives a low overall stock score primarily due to significant financial challenges, including continuous net losses, high debt, and negative cash flows. The technical analysis also suggests bearish momentum. Although valuation metrics are poor, recent corporate actions, such as acquisitions and restructuring, provide some hope for future improvement. However, these are not sufficient to outweigh the current financial and operational challenges facing the company.
To see Spark’s full report on FOXO stock, click here.
More about FOXO Technologies
Average Trading Volume: 7,710,747
Technical Sentiment Signal: Sell
Current Market Cap: $233.4K
Learn more about FOXO stock on TipRanks’ Stock Analysis page.